| Trial ID: | L1123 |
| Source ID: | NCT01635387
|
| Associated Drug: |
Aliskiren
|
| Title: |
RAAS Inhibitor Drugs in Dialysis Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|End Stage Renal Disease
|
| Interventions: |
DRUG: aliskiren
|
| Outcome Measures: |
Primary: time to first clinical event (among mortality from any cause, cardiac event including myocardial infarction, need for coronary angioplasty or coronary bypass surgery, ischaemic stroke, new-onset heart failure, new-onset atrial fibrillation), 30 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Campania Luigi Vanvitelli | Collaborators: IRCCS San Raffaele
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
350
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-02
|
| Completion Date: |
2012-09
|
| Results First Posted: |
|
| Last Update Posted: |
2012-07-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01635387
|
